UK officials cheer new study that shows Oxford-AstraZenenca vaccine may substantially reduce the spread of coronavirus. “Absolutely superb.” bbc.com/news/uk-559139…
*Oxford researchers report AstraZeneca vaccine was 76% effective at preventing symptomatic infection for three months after a single dose.
*Study supports UK decision to delay 2nd dose. cnbc.com/2021/02/03/del…
*Study supports UK decision to delay 2nd dose. cnbc.com/2021/02/03/del…
#CORONAVIRUS UPDATE 2/3/2021:
*Oxford/AstraZeneca aims for new variant vaccine by autumn.
*Most Covid patients develop antibodies that protect from reinfection for at least 6 months.
*Mexico authorizes Russia’s Sputnik V virus vaccine.
theguardian.com/world/live/202…
*Oxford/AstraZeneca aims for new variant vaccine by autumn.
*Most Covid patients develop antibodies that protect from reinfection for at least 6 months.
*Mexico authorizes Russia’s Sputnik V virus vaccine.
theguardian.com/world/live/202…
GlaxoSmithKline and Germany’s CureVac sign £132m deal to develop multi-variant #Covid19 vaccine. theguardian.com/world/2021/feb…
*New study shows adults aged 20-49 have been responsible for the vast majority of #coronavirus transmission.
*Same study (published by Science magazine) shows school reopenings increased total infections by about 26% as of October; deaths by about 6%.
axios.com/young-adults-c…
*Same study (published by Science magazine) shows school reopenings increased total infections by about 26% as of October; deaths by about 6%.
axios.com/young-adults-c…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
